Intramuscular epinephrine as first-line treatment of anaphylaxis: still concerns about its safety in the elderly?| JOURNAL OF GERONTOLOGY AND GERIATRICS
Vol. 66: ISSUE 1 - MARCH 2018
Geriatrics and Gerontology Elsewhere - Commentaries
Published: 2018-03-15
PDF

Intramuscular epinephrine as first-line treatment of anaphylaxis: still concerns about its safety in the elderly?

Nursing home “Casa Serena”, ASL Modena, Sassuolo (MO), Italy
Dermatological Clinic, Department of Biomedical Science and Human Oncology, University of Bari Medical School, Policlinico, Bari, Italy
Department of Interdisciplinary Medicine, University of Bari, Italy
Allergy Unit, Hospital Santo Spirito, ASL Alessandria, Casale Monferrato (AL), Italy
Anahylaxis Epinephrine Adrenaline

Abstract

Anaphylaxis is a severe condition that can affect patients of all ages. Elderly patients must be considered
particularly vulnerable to severe anaphylaxis due to many risk factors such as concomitant diseases and medications.
Intramuscular administration of epinephrine is recommended as fist-line therapy for anaphylaxis and
its use should be promoted in every setting. Intramuscular epinephrine is recognized as generally safe and
there are no absolute contraindications to the prescription of self-injectable adrenaline in older patients at risk
of anaphylaxis.

Affiliations

S. Cernesi

Nursing home “Casa Serena”, ASL Modena, Sassuolo (MO), Italy

R. Buquicchio

Dermatological Clinic, Department of Biomedical Science and Human Oncology, University of Bari Medical School, Policlinico, Bari, Italy

M.T. Ventura

Department of Interdisciplinary Medicine, University of Bari, Italy

E. Boni

Allergy Unit, Hospital Santo Spirito, ASL Alessandria, Casale Monferrato (AL), Italy

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright

© Società Italiana di Gerontologia e Geriatria (SIGG) , 2018

How to Cite

[1]
Cernesi, S., Buquicchio, R., Ventura, M. and Boni, E. 2018. Intramuscular epinephrine as first-line treatment of anaphylaxis: still concerns about its safety in the elderly?. JOURNAL OF GERONTOLOGY AND GERIATRICS. 66, 1 (Mar. 2018), 43-45.
  • Abstract viewed - 246 times
  • PDF downloaded - 100 times